Copyright
©The Author(s) 2022.
World J Gastrointest Pharmacol Ther. Jul 5, 2022; 13(4): 57-66
Published online Jul 5, 2022. doi: 10.4292/wjgpt.v13.i4.57
Published online Jul 5, 2022. doi: 10.4292/wjgpt.v13.i4.57
Table 3 Prevalence and prevalence ratio of low bone mineral density according to demographic, clinical, and nutritional characteristics of patients with ulcerative colitis
Variable | Prevalence of low BMD, n (%) | PR (95%CI) | P value | |
Sex | ||||
Female | 15 | 57.7 | 1.00 | |
Male | 13 | 31.0 | 1.86 (1.07 – 3.26) | 0.029 |
Age group | ||||
< 45 yr | 20 | 39.2 | 1.00 | |
≥ 45 yr | 8 | 47.1 | 1.38 (0.46 – 4.16) | 0.583 |
Regular physical activity | ||||
Yes | 3 | 18.8 | 1.00 | |
No | 25 | 48.1 | 2.56 (0.89 – 7.39) | 0.081 |
Steroid use | ||||
No | 23 | 38.3 | 1.00 | |
Yes | 5 | 62.5 | 1.63 (0.87 – 3.05) | 0.126 |
Steroid use | ||||
< 3 mo | 1 | 25.0 | 1.00 | |
≥ 3 mo | 5 | 62.5 | 2.50 (0.42 – 14.8) | 0.313 |
BMI classification | ||||
Not overweight | 23 | 51.1 | 1.00 | |
Overweight | 5 | 21.7 | 0.43 (0.19 – 0.97) | 0.043 |
WC classification | ||||
Normal | 21 | 52.5 | 1.00 | |
Elevated | 6 | 23.1 | 0.44 (0.21 – 0.94) | 0.034 |
BF classification (%) | ||||
Normal | 10 | 45.5 | 1.00 | |
Elevated | 18 | 39.1 | 0.86 (0.48 – 1.54) | 0.614 |
- Citation: Lopes MB, Lyra AC, Rocha R, Coqueiro FG, Lima CA, de Oliveira CC, Santana GO. Overweight and abdominal fat are associated with normal bone mineral density in patients with ulcerative colitis. World J Gastrointest Pharmacol Ther 2022; 13(4): 57-66
- URL: https://www.wjgnet.com/2150-5349/full/v13/i4/57.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v13.i4.57